US stocks rallied to fresh records after both a robust payroll report showed the labor market recovery is back on track and on growing optimism the US is close to winning the war against COVID after Pfizer’s promising data with their oral antiviral treatment. The Pfizer study showed its pill reduced risk of hospitalization or death from COVID by 89%. Pfizer shares surged, while many COVID vaccines stocks tumbled.
A strong nonfarm payroll report will not change the Fed’s wait-and-see stance on interest rate hiking, but it will have traders fixate on next week’s inflation report. Treasury yields continued to slide lower. The 10-year Treasury fell 7.7 basis points to 1.450%.
The Biden administration is struggling to get the economic package and infrastructure bill passed, but we could see a House vote later today. Changes are being made to the Build Back Better legislation and it is still unclear if the Senate will approve it. This will get done at some point before year end and is mostly priced in by Wall Street.
NFP
The US economy saw 531,000 jobs added in October and the prior month was revised 118,000 jobs higher. This was a strong labor market report, but it was far from perfect. It would have been nice to see the participation rate increase, which is why you should take the larger-than-expected dip with the unemployment rate with a grain of salt. The participation rate stayed at 61.6% and the jobless rate fell to 4.6%.
Average hourly earnings for private sector workers increased by 4.9% compared to a year ago. The jury is still out if higher wages will lead to higher inflation, but right now it is hard to argue that it won’t.
The labor market recovery is back on track, but it will still take several months to get to maximum employment. Alongside the Pfizer COVID pill news, this strong NFP report should ease some of the supply chain problems and that will make some investors embrace the reopening trade.
Content is for general information purposes only. It is not investment advice or a solution to buy or sell securities. Opinions are the authors; not necessarily that of OANDA Business Information & Services, Inc. or any of its affiliates, subsidiaries, officers or directors. If you would like to reproduce or redistribute any of the content found on MarketPulse, an award winning forex, commodities and global indices analysis and news site service produced by OANDA Business Information & Services, Inc., please access the RSS feed or contact us at info@marketpulse.com. Visit https://www.marketpulse.com/ to find out more about the beat of the global markets. © 2023 OANDA Business Information & Services Inc.
Ed Moya
His particular expertise lies across a wide range of asset classes including FX, commodities, fixed income, stocks and cryptocurrencies.
Over the course of his career, Ed has worked with some of the leading forex brokerages, research teams and news departments on Wall Street including Global Forex Trading, FX Solutions and Trading Advantage. Prior to OANDA he worked with TradeTheNews.com, where he provided market analysis on economic data and corporate news.
Based in New York, Ed is a regular guest on several major financial television networks including CNBC, Bloomberg TV, Yahoo! Finance Live, Fox Business, cheddar news, and CoinDesk TV. His views are trusted by the world’s most respected global newswires including Reuters, Bloomberg and the Associated Press, and he is regularly quoted in leading publications such as MSN, MarketWatch, Forbes, Seeking Alpha, The New York Times and The Wall Street Journal.
Ed holds a BA in Economics from Rutgers University.
Latest posts by Ed Moya (see all)
- Market Insights Podcast – Powell struggles to deliver a hawkish hold - 1 November 2023
- Fed React: USD/JPY softer after Fed fails to deliver hawkish hold - 1 November 2023
- EUR/USD: Dollar wavers on slower pace of Treasury Refunding Sales and mixed labor data - 1 November 2023